“Real-World Efficacy of Ramucirumab Plus Paclitaxel With or Without Nivolumab in Advanced Gastric and Gastroesophageal Junction Cancers”. Annals of Medical Research 33, no. 3 (March 25, 2026): 091–098. Accessed March 30, 2026. http://www.annalsmedres.org/index.php/aomr/article/view/4905.